v3.25.4
Stockholders Deficit (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Oct. 08, 2025
Sep. 03, 2024
Mar. 05, 2024
Feb. 02, 2024
Dec. 24, 2024
Sep. 30, 2024
Aug. 31, 2024
Mar. 21, 2024
Mar. 18, 2024
Dec. 31, 2025
Dec. 31, 2024
Dec. 11, 2025
Jun. 30, 2025
Sep. 13, 2024
Jun. 22, 2024
May 16, 2024
Dec. 31, 2023
Net proceeds                   $ 7,400,000              
Net proceeds from issuance of warrants                   $ 7,704,540              
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period]                     $ 3,046,552            
Weighted average exercise price                     $ 2.77            
Total Stock, shares authorized                   205,000,000 205,000,000            
Number of shares issued upon exercise of stock options during the period                   443,179 415,218            
Warrant Exercise Price Per Share                   $ 4.35              
Exercise price                   $ 5.54              
Expected life                   3 years              
Expected volatility                   69.00%              
Risk free interest rate                   4.36%              
Equity issuance cost                   $ 6,500,000              
Common stock, shares authorized                   200,000,000 200,000,000            
Share-Based Compensation                   $ 1,629,992 $ 1,362,822            
Exercise price per share                   $ 3.39 $ 3.47            
Common stock, par value                   $ 0.0001 $ 0.0001     $ 2.65      
Preferred stock, shares authorized                   5,000,000 5,000,000            
Stock Issued During Period, Shares, Issued for Services               15,000                  
Preferred stock, par value                   $ 0 $ 0            
Proceeds from stock option exercises                   $ 149,288 $ 240,507            
Exercise price per share                     $ 0.58            
Common Stock SARs outstanding                   $ 1,758,000              
Stock appreciation rights plan description                   February 17, 2022, the Company’s Board of Directors approved the 2022 Stock Appreciation Rights Plan (the “SAR Plan”) to issue a maximum of 1,500,000 stock appreciation rights (“SARs”), which was later adjusted to 2,637,150 SARs after the Merger              
Exercise Price                   $ 0.12              
Number of shares vested upon milestone           1,250,000                      
Number of shares issued upon vesting           1,160,906                      
Common stock shares, outstanding                   34,368,162 30,588,413            
Common stock, shares issued                   34,368,162 30,588,413     86,198   50,000  
Weighted average exercise price of outstanding options                   $ 1.68 $ 1.04           $ 0.54
Warrants outstanding                   22,488,828 21,961,690   21,948,388       19,443,314
Awards outstanding                   6,792,880              
Aggregate intrinsic value                   $ 9,124,344              
Platinum Convertible Note [Member]                                  
Warrants to Purchase Common Stock by each founders   2,882,883   189,334         137,367                
Warrants to Purchase Common Stock forfeited shares                 51,967                
Number of shares issued upon exercise of stock options during the period                     163,669            
Exercise Price       $ 3.69717                          
Platinum Senior Secured Convertible Promissory Note [Member]                                  
Debt Converted Into Equity Amount                     $ 2,000,000            
Common Stock Shares Issued                     879,051            
Exercise price per share                     $ 2.275            
2023 Equity Incentive Plan [Member]                                  
Number of shares issued upon exercise of stock options during the period                   443,179              
Proceeds from stock option exercises                   $ 149,288              
Weighted average exercise price of outstanding options                   $ 0.34              
Stock based compensation expense                   $ 1,103,325 $ 570,614            
Shares available for grant under share-based compensation plan                   4,000,000              
Share-based compensation arrangement, annual increase in authorized shares                   2.00%              
September 3 2024 [Member]                                  
Combined price per shares   $ 2.775                              
Warrants to purchase shares of common stock   2,882,883               216,216              
Warrant Exercise Price Per Share   $ 3.47               $ 2.65              
Warrants exercised         2,882,883                        
September 27 2024 [Member]                                  
Warrants to purchase shares of common stock                   220,000              
Warrant Exercise Price Per Share                   $ 2.36              
December 24 2024 [Member]                                  
Net proceeds from issuance of warrants                   $ 7,400,000              
Warrants to purchase shares of common stock                   2,162,162              
Common stock exercise price per share                   $ 4.50              
Warrants exercise price                   $ 2.65              
Common stock warrants exercisable                   2,882,883              
Gross proceeds from Issuance of Warrants                   $ 7,600,000              
Stock Incentive Plan                                  
Share-Based Compensation             $ 205,879                    
Weighted average exercise price of outstanding options                   $ 1.68              
Description of modification of share-based payment award                   the Company cancelled out-of-the money options to exercise 300,000 shares held by current employees and replaced them with 525,000 options at lower exercise prices. The new options were subject to the same service-based vesting schedule as the original options              
Total unrecognized costs                   $ 3,824,252              
Option expected over period                   3 years              
Awards outstanding                   6,792,880              
Warrant Inducement Agreement [Member]                                  
Number of shares issued upon exercise of stock options during the period         2,882,883                        
Warrant Exercise Price Per Share         $ 2.65                        
Investors [Member]                                  
Warrant Exercise Price Per Share                   $ 4.50              
Shares Issued Upon Exercise of Public Warrants                   13,502              
Proceeds from Exercise of Public Warrants                   $ 60,759              
Airship AI Holdings Inc [Member]                                  
Common stock, shares authorized                       2,000,000          
Employee [Member]                                  
Purchase shares of common stock                   1,816,000 1,590,000            
Common stock exercise price per share                   $ 3.39 $ 3.47            
Employee 1 [Member]                                  
Purchase shares of common stock                   107,500 300,000            
Common stock exercise price per share                   $ 2.95 $ 6.85            
Warrants [Member]                                  
Dividend yield                   0.00% 0.00%            
Warrant Exercise Price Per Share                   $ 1.77              
Exercise price                   $ 6.20              
Expected life                   4 years              
Expected volatility                   61.20% 69.00%            
Risk free interest rate                   3.74%              
Aggregate intrinsic value                   $ 3,129,290              
Warrants outstanding                   22,488,828              
Common Stocks [Member]                                  
Number of shares issued upon exercise of stock options during the period 2,162,162                                
Warrant Exercise Price Per Share $ 6.20                                
Professional Fees $ 231,593                                
Purchase shares of common stock                     11,812            
Common stock exercise price per share                     $ 1.64            
Exercise price per share $ 4.50                                
New warrants issued 2,702,702                                
Proceeds from issuance of warrants $ 9,729,729                                
Common Stocks [Member] | Invester [Member]                                  
Debt Converted Into Equity Amount     $ 250,000                            
Common Stock Shares Issued     70,502                            
Common Stocks [Member] | Investor 1 [Member]                                  
Debt Converted Into Equity Amount     $ 350,000                            
Common Stock Shares Issued     98,702                            
Platinum Shares Common Stock [Member]                                  
Common stock, shares issued                             232,360    
Stock Options [Member]                                  
Number of shares issued upon exercise of stock options during the period                   443,179 415,218            
Number of shares issued upon exercise of stock options during the period, value                   $ 149,288 $ 240,567            
Weighted average exercise price of stock options exercised during the period                   $ 0.34 $ 0.58            
Warrants Purchase Common Stock [Member] | Investors [Member]                                  
Number of shares issued upon exercise of stock options during the period 2,162,162                   163,669            
Dividend yield                   0.00%              
Warrant Exercise Price Per Share $ 6.20                 $ 4.50 $ 4.92            
Shares Issued Upon Exercise of Public Warrants                   13,502              
Proceeds from Exercise of Public Warrants $ 9,729,729                 $ 60,759              
Exercise price                   $ 5.14              
Gross proceeds from other equity                   $ 9,700,000              
Expected life                   4 years              
Expected volatility                   61.20%              
Risk free interest rate                   3.74%              
Equity issuance cost                   $ 6,200,000              
Exercise price per share $ 4.50                                
New warrants issued 2,702,702